- Sort by Product ID
- Display 30 Products per page
Published: October 4, 2016 | Price: $2,396.00 – $4,792.00
IVD in the Middle East (Egypt, Turkey, Saudi Arabia, United Arab Emirates, Israel, Jordan, Other Mideast) In vitro diagnostic (IVD) companies are casting their nets in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. The Middle East is an underserved region with large market potential. IVD in the Middle East provides data on the developments in the IVD industry in the Middle East, including: Egypt...Published: August 22, 2016 | Price: $3,600.00 – $7,200.00
This Kalorama Information report, The Worldwide Market for In Vitro Diagnostic Tests, represents the 10th edition of this comprehensive look at the IVD industry. At 1,600 pages report provides market size estimates and projections for the entirety of the clinical diagnostics testing market. It also profiles hundreds of competitors, notes significant acquisitions and other deals, discusses trends and breaks out regional and country markets. The report provides market size and forecasts to 2021 for defined segments of the IVD...Published: July 28, 2016 | Price: $6,000.00 – $12,000.00
This combined report offering allows customers of Kalorama research to have two titles, combining Kalorama's authoritative volume covering the entire world POC market with its more focused report on molecular POC systems. The World Market for Point of Care (POC) Diagnostics presents current analysis of the POC diagnostics industry and the role it plays in medical practice. This report takes an in-depth look at the POC diagnostic testing market, both professional and self-testing. The report provides data on the size...Published: June 27, 2016 | Price: $3,196.00 – $6,720.00
United States Market for In Vitro Diagnostic Tests United States Market for In Vitro Diagnostic Tests takes a considered look at the U.S. in vitro diagnostics (IVD) market and examines what current market trends mean for diagnostic manufacturers and investors. This report includes important tools for business planners. Included are market size estimates and forecasts for the following U.S. IVD segments: Clinical Chemistry Market (2015/2020) Identification and Antibiotic Susceptibility Testing (ID/AST) Microbiology (Traditional) Market – Automated ID/AST, Manual/Semi‐Auto ID/AST, Blood...Published: June 7, 2016 | Price: $3,360.00 – $6,720.00
The World Market for Companion Diagnostics The World Market for Companion Diagnostics examines revenues for companion diagnostic and personalized medicine diagnostics. Market analysis in this market review includes regional coverage – North America, Europe, rest of world – of the world IVD companion diagnostics test market (in vitro diagnostic kits) for 2015-2020, coverage by disease segment – cancer and other – of the world IVD companion diagnostics test market for 2015, and coverage of the worldwide companion diagnostics test services...Published: April 20, 2016 | Price: $2,000.00 – $4,000.00
Blood Testing Market in China (Typing, Immunoassay, NAT Testing) With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. Blood Testing Market in China offers the most current look at the blood testing IVD market in China, including tests for blood typing, immunoassay-based tests and NAT Tests. The report provides market analysis and data on the blood testing market environment in China, including: Blood...Published: March 24, 2016 | Price: $2,000.00 – $4,000.00
Cancer Markers Cancer Markers contains revenue assessment, analysis, and competitive review for tests for oncology using biomarkers. Multiple firms manufacture a range of technologies – histology/cytology, immunohistochemistry, in situ hybridization, immunoassays - tumor markers, flow cytometry, rapid tests, and molecular marker-based technologies – to determine risk for cancer, screen for cancer, test for cancer, and help in prognosis and personalization of therapy. Cancer Markers provides the following information: global cancer biomarkers diagnostic revenues, 2015 and 2020 (IHC, ISH, immunoassays, flow,...Published: February 26, 2016 | Price: $3,360.00 – $6,720.00
Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the developing world.bThe Market and Potential for Molecular Point of Care Diagnostics examines the major segments of molecular POC diagnostics, exploring in-depth current sales and market opportunity and providing the following market information: Molecular POC Market for...Published: February 5, 2016 | Price: $2,000.00 – $4,000.00
Novel Autism Diagnostics Novel Autism Diagnostics reviews selected autism test innovations, summarizing many of the current approaches to autism diagnostics, which include molecular testing, pre-disposition screening, targeted sequencing-based testing, next-generation sequencing with modeling, genetic risk assessment / testing, cloud platform approaches, microarrays, end-to-end sequencing, gene variants, and blood-based genetic testing. The report looks at the companies behind these testing approaches as well. Asuragen, Google Genomics, Illumina, and LabCorp are among the companies discussed within the report’s competitive analysis.Published: January 26, 2016 | Price: $796.00 – $1,592.00
Point of Care (POC) Cholesterol Testing Market Point of Care (POC) Cholesterol Testing Market presents the revenue picture for cholesterol testing performed at or near the site where the patient is located. The following data regarding the POC cholesterol market are provided: world POC cholesterol testing revenue estimates, 2012-2020; POC cholesterol self-testing revenue estimates, 2015 and 2020; POC cholesterol professional testing revenue estimates, 2015 and 2020; world POC cholesterol testing revenue estimates and market share of leading manufacturers, 2014; and...Published: January 22, 2016 | Price: $3,600.00 – $6,320.00
This Kalorama Information In Vitro Diagnostics (IVD) Market Bundle represents three reports, as published in 2015. These reports, representing over 2,000 pages of market information, delve into some of the fastest-growing and most critical areas of clinical diagnostics: cancer diagnostics, molecular assays and systems, and infectious disease tests. Together, these three in vitro diagnostic areas represent nearly one-half of the IVD market and the best growth opportunities. The Bundle features the exact published content in each of the three major Kalorama...Published: January 20, 2016 | Price: $2,000.00 – $4,000.00
Blood Screening and Typing Markets Blood Screening and Typing Markets analyzes the infectious disease blood typing and the infectious disease blood screening opportunities, including complete revenue estimates of the blood screening and typing markets: global blood typing and screening revenues, 2015 and 2020 (ABO grouping, immunoassay screen, NAT screen); selected blood typing innovations; blood typing by country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%); infectious disease blood typing market portion by...Published: January 6, 2016 | Price: $3,360.00 – $6,720.00
IVD in India IVD in India provides analysis of the Indian IVD industry and presents projections to 2025, featuring estimates of the total opportunity and its component sectors, including: total IVD revenues in India, 2015-2025, IVD revenues in India by market sector (immunoassays, clinical chemistry, hematology, POC/OTC, molecular, urinalysis, other) in 2015, IVD revenues in India by market sector (immunoassays, clinical chemistry, hematology, POC/OTC, molecular, urinalysis, other) in 2020, and IVD revenues in India by market sector (immunoassays, clinical chemistry,...Published: January 1, 2016 | Price: $2,396.00 – $4,792.00
The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Others) In Situ Hybridization, HPV Testing, Circulating Tumor Cells and Flow Cytometry are important histology and cytology approaches to testing. In situ hybridization and more specifically fluorescent in situ hybridization (FISH) techniques use DNA probes to detect pathogens and molecular structures in cells. More recently flow cytometry techniques and other cell capture devices allow lab professionals to select targeted cells that can be further analyzed with PCR, sequencing...Published: January 1, 2016 | Price: $3,360.00 – $6,720.00
The Market for Direct-to-Consumer (DTC) Laboratory Testing This Kalorama Information report provides reliable business intelligence on the growing Direct-to-Consumer (DTC) Testing market. The report details the companies that are providing this service and innovations that have recently occurred in the market. The report provides the trends driving growth, and stats influencing companies in the industry, the incidence of diseases in the U.S. and worldwide, demographics; life expectancy, and company strategies. Information is presented as a U.S market report. Specific information...Published: December 29, 2015 | Price: $696.50 – $1,393.00
Point of Care (POC) Pregnancy and Fertility Testing Market The female reproductive system is complex both in structure and in function. From birth to senescence, the organs of the female reproductive system function in concert with each other, with the brain, and with other endocrine organs. This integrated functioning constitutes some of the most intricate and elegant processes of the human body. Because the functioning of the female reproductive system has an enormous impact on the life of the individual...Published: December 17, 2015 | Price: $349.30 – $700.00
Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market Point of Care (POC) Urinalysis Testing Market and Urinalysis Drugs of Abuse Testing Market examines the urine strip segment of the global POC professional testing and self-testing markets and the urinalysis segment of the POC professional drugs of abuse testing market, including: Selected Dipstick Urinalysis Systems, 2014 Global POC Urine Strip Testing Market Analysis: 2012-2019 POC Urine Strip Self-Testing Market Analysis, 2014 and 2019 POC Urine...Published: December 14, 2015 | Price: $175.00 – $350.00
Hologic: Company Profile Hologic: Company Profile examines this leading developer, manufacturer, and supplier of premium diagnostic products, medical imaging systems and surgical products. The company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. Hologic, Inc. is a leading developer, manufacturer and supplier of products dedicated to women’s health. Hologic provides products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, permanent contraception, osteoporosis assessment, preterm...Published: November 9, 2015 | Price: $250.00 – $500.00
QIAGEN: Company Profile QIAGEN, a leading global provider of sample and assay technologies, markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). QIAGEN: Company Profile examines the global healthcare company whose sample technologies isolate and process DNA, RNA and proteins from biological samples such as blood...Published: November 2, 2015 | Price: $250.00 – $500.00
Roche Diagnostics: Company Profile Roche Diagnostics: Company Profile examines the Swiss global research-based healthcare company. With product sales almost twice that of its nearest competition, Roche is the world's largest supplier of clinical diagnostics products. Roche is as well the global world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche is also the world's largest biotech company, with 14 biopharmaceuticals on the market. Further, Roche's personalized healthcare strategy aims at providing medicines...Published: November 1, 2015 | Price: $3,500.00 – $7,000.00
The World Market for Infectious Disease Diagnostic Tests World Market for Infectious Disease Tests provides detailed market estimates and forecasts for four major areas of infectious disease testing, including identification and antibiotic susceptibility testing, immunoassays, molecular testing and blood screening and subsegments within. POC and home testing markets for infectious disease are also provided. Sales and forecasts of infectious disease reagents are made through to 2019. Emerging products and markets are described; key players and strategies discussed and competitive trends...Published: October 26, 2015 | Price: $499.00 – $1,000.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market documents some 240 acquisitions that have taken place from 2012 to October 2015 in the extremely dynamic IVD industry. And this is likely only a small portion of what is really happening in the market; more deals are still to come. In vitro diagnostic (IVD) companies have been very busy with respect to acquisitions in an attempt to augment market share in an increasingly competitive market....Published: October 1, 2015 | Price: $1,995.00 – $3,995.00
Clinical Laboratory Services Market This report, Clinical Laboratory Services Market, provides an in-depth market overview, a total market analysis, analysis by laboratory type, and by routine and specialty testing and a review of the latest trends driving growth. Revenues and forecasts, segment breakouts and market share presented are for the U.S. market, but international clinical lab service markets are estimated and forecasted in this report. Laboratory services are a key component of the healthcare system and an important part of...Published: September 30, 2015 | Price: $1,999.00 – $3,995.00
Molecular tests are used in just about every facet of laboratory medicine: infectious diseases, inherited diseases, coagulation, transplant medicine, prenatal and postnatal screening and cancer. In The World Market for Molecular Diagnostics, 6th Edition, Kalorama IVD market analyst Shara Rosen, R.T., MBA provides authoritative and complete analysis of the molecular testing industry. In this report, exclusive market sizing and forecasts are provided for the following diagnostic segments: Cancer Markers & PGx Histology (In situ hybridization, HPV) Microbiology/Virology (HAI; HIV; Hepatitis;...Published: September 16, 2015 | Price: $1,995.00 – $3,995.00
Diabetes is a leading cause of death and disability in the worldwide. It increases the risk for heart disease, end-stage renal disease, blindness, amputation, and complications of pregnancy and is ranked as the sixth leading cause of death. Disease prevalence is driving sales of monitoring equipment. The glucose monitoring device and diabetes management market is focused on utilizing advancements recently introduced to provide easier-to-use products and more accurate glucose monitoring. This Kalorama information report, The Global Glucose Monitoring Market provides...Published: September 11, 2015 | Price: $1,995.00 – $3,995.00
The World Market for Cancer Diagnostics, 2014-2019, 6th Edition (Histology [ISH, IHC, HPV, Pap], Flow Cytometry, PSA, CEA, Liquid Biopsy, FOB and Other Rapid, Image Cytometry, Sequencing, Digital Pathology, Molecular Assays) Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and early detection of cancer recurrence. The World Market for Cancer Diagnostics, 6th Edition., as well as relevant industry merger data provided by Kalorama Information,...Published: August 19, 2015 | Price: $1,995.00 – $3,990.00
The IVD Market in Vietnam presents current analysis of the Vietnamese IVD industry. Vietnam has demonstrated fast economic growth in recent years. Increases in foreign investment, wages, trade, industrialization and tourism have led to economic growth higher than that of many other economies in Asia. As a result, IVD companies searching for emerging market areas to pursue growth that is no longer possible in developed nations have targeted Vietnam. The report takes an in-depth look at the market, providing data...Published: June 11, 2015 | Price: $1,995.00 – $3,995.00
IVD in China Market Outlook 2014-2024 With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. In the past ten years, China has led all major world economies in the average rate of growth in real GDP, total health expenditures, and government health expenditures. As an in vitro diagnostics (IVD) market, China trails only the populous, developed markets of the United States, western European countries,...Published: June 2, 2015 | Price: $1,995.00 – $3,995.00
The World Market for Point of Care (POC) Diagnostics Visit our 'Point of Care Testing' curated page for complete industry coverage. Clinical diagnostic tests performed outside the central laboratory or decentralized testing are generally known as point of care (POC) diagnostic tests. The increasing introduction of transportable, portable, and handheld diagnostic instruments has resulted in the migration of point of care diagnostic testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and...Published: May 1, 2015 | Price: $1,995.00 – $3,995.00
The Market for Prenatal, Newborn and Carrier Genetic Testing The Market for Prenatal, Newborn and Carrier Genetic Testing discusses the technologies and tests used in chromosomal analysis and in the diagnosis of inherited disorders and the detection of carriers of inherited diseases. The growing global genetic testing laboratory services market is discussed, including: carrier testing prenatal testing newborn screening neonatal/pediatric testing testing for adult onset genetic disorders The growing number of genetic tests has been made possible by advances in...